Vaxart, Inc.
Index- P/E- EPS (ttm)-0.83 Insider Own0.60% Shs Outstand131.61M Perf Week0.80%
Market Cap101.76M Forward P/E- EPS next Y-0.82 Insider Trans2.35% Shs Float130.15M Perf Month-2.30%
Income-104.60M PEG- EPS next Q-0.19 Inst Own39.50% Short Float / Ratio16.62% / 13.46 Perf Quarter-2.74%
Sales0.20M P/S508.81 EPS this Y-45.50% Inst Trans13.44% Short Interest21.63M Perf Half Y-67.52%
Book/sh0.84 P/B0.90 EPS next Y-19.30% ROA-60.60% Target Price6.12 Perf Year-85.53%
Cash/sh0.71 P/C1.06 EPS next 5Y- ROE-79.50% 52W Range0.70 - 5.32 Perf YTD-21.25%
Dividend- P/FCF- EPS past 5Y60.80% ROI-97.40% 52W High-85.78% Beta0.82
Dividend %- Quick Ratio5.50 Sales past 5Y-55.10% Gross Margin- 52W Low8.10% ATR0.06
Employees164 Current Ratio5.50 Sales Q/Q- Oper. Margin- RSI (14)43.22 Volatility6.24% 7.42%
OptionableYes Debt/Eq0.00 EPS Q/Q-9.80% Profit Margin- Rel Volume0.60 Prev Close0.80
ShortableYes LT Debt/Eq0.00 EarningsMar 15 AMC Payout- Avg Volume1.61M Price0.76
Recom2.00 SMA20-3.22% SMA50-16.80% SMA200-62.96% Volume996,003 Change-5.47%
Dec-29-21Resumed Jefferies Buy $13 → $12
Nov-02-21Initiated Cantor Fitzgerald Overweight $15
Jun-29-21Downgrade B. Riley Securities Buy → Neutral $13 → $9
Jun-24-21Initiated Jefferies Buy $13
Jun-11-21Initiated Piper Sandler Overweight $18
Aug-12-20Reiterated H.C. Wainwright Buy $7 → $17
Jul-13-20Initiated B. Riley FBR Buy $22
Mar-29-23 08:00AM
Mar-18-23 02:56AM
Mar-17-23 08:00AM
Mar-15-23 04:01PM
Mar-08-23 04:05PM
08:00AM Loading…
Feb-14-23 08:00AM
Jan-18-23 09:00AM
Jan-09-23 08:27AM
Dec-19-22 08:00AM
Dec-01-22 08:00AM
Nov-22-22 08:30AM
Nov-11-22 05:47AM
Nov-08-22 05:45PM
Nov-01-22 10:01AM
05:06AM Loading…
Oct-25-22 05:06AM
Oct-20-22 08:30AM
Oct-10-22 08:00AM
Oct-04-22 06:20AM
Sep-07-22 08:30AM
Sep-01-22 06:30AM
Aug-31-22 04:30PM
Aug-25-22 04:05PM
Aug-08-22 05:35PM
Aug-05-22 08:00AM
Aug-03-22 07:55AM
Jul-29-22 10:56AM
04:05PM Loading…
Jul-28-22 04:05PM
Jul-27-22 08:00AM
Jul-20-22 08:30AM
Jul-14-22 08:00AM
Jul-01-22 09:00AM
Jun-30-22 08:00AM
Jun-29-22 06:00AM
Jun-16-22 04:05PM
Jun-08-22 09:05AM
Jun-07-22 10:30AM
Jun-03-22 08:00AM
Jun-02-22 08:45AM
May-20-22 03:33PM
May-19-22 08:30AM
May-18-22 05:51AM
May-16-22 06:00AM
May-13-22 04:17PM
May-09-22 05:46PM
May-04-22 02:25PM
Apr-27-22 06:30AM
Apr-14-22 08:30AM
Apr-07-22 05:51AM
Apr-06-22 05:21AM
Mar-29-22 10:12AM
Mar-26-22 11:15AM
Mar-24-22 11:37AM
Mar-09-22 06:30AM
Feb-24-22 07:10PM
Feb-23-22 06:15AM
Feb-17-22 03:02PM
Feb-16-22 10:58AM
Feb-15-22 05:55PM
Feb-14-22 08:00AM
Feb-11-22 11:23AM
Feb-09-22 01:23PM
Feb-07-22 12:00PM
Jan-29-22 06:55AM
Jan-27-22 06:33AM
Jan-12-22 11:10AM
Jan-10-22 07:55AM
Jan-04-22 08:00AM
Dec-30-21 02:59PM
Dec-21-21 10:37AM
Dec-20-21 06:23AM
Dec-16-21 09:05AM
Dec-15-21 06:00AM
Dec-14-21 05:51AM
Dec-06-21 01:45PM
Dec-03-21 03:18PM
Dec-01-21 03:14PM
Nov-23-21 08:00AM
Nov-21-21 06:00AM
Nov-18-21 04:02PM
Nov-16-21 08:00AM
Nov-11-21 04:01PM
Nov-05-21 06:25AM
Nov-04-21 05:25PM
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dysplasia caused by human papillomavirus. The company is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watson W. MarkDirectorDec 28Buy0.7620,00015,14020,000Dec 28 05:25 PM
Yedid Robert A.DirectorAug 19Option Exercise0.9426,24024,77437,355Aug 22 06:06 PM
Ahmad FuadInterim CFOJun 22Buy3.225,00016,1005,000Jun 23 04:32 PM
Tucker SeanSVP, Chief Scientific OfficerApr 22Option Exercise0.7740,00030,800127,631Apr 25 04:40 PM